We previously characterized multiple interactions between chemokine and opioid G protein-coupled receptors (GPCR), and we found both μ and δ-opioid receptors cross-desensitize CCR1, CCR2, CCR5, but not CXCR4. Here we report that the κ-opioid receptor (KOR) is able to crossdesensitize CXCR4, and this phenomenon is bi-directional. Chemotactic responses by KOR activation are diminished with prior activation of CXCR4. Additionally, calcium mobilization assays show these cross-desensitization processes occur within seconds of receptor activation, and target receptor internalization is not responsible for desensitization between these receptors. These results have implications for several essential processes including neuronal and lymphocyte development, inflammatory responses, and pain/sensitivity.
Introduction
Opioids have roles in the central and peripheral nervous systems for the control of pain sensations. They also function as regulators of cellular and humoral immune responses (Carr et al., 1996; McCarthy et al., 2001 ) and have been shown to regulate expression of chemokines as well as chemokine receptors (Steele et al., 2003) . The opioid receptors and chemokine receptors are both members of the seven transmembrane G protein-coupled receptor (GPCR) super-family. Three primary types of opioid receptors have been cloned and are designated δ, κ, and μ (Chen et al., 1993; Evans et al., 1992; Kieffer et al., 1992; Li et al., 1993; Yasuda et al., 1993) . Chemokines and chemokine receptors are involved in leukocyte recruitment to sites of inflammation, and are also involved in neuronal development (Stumm and Hollt, 2007; Stumm et al., 2003) . Classification of the chemokine receptors, designated C, CC, CXC, or CX 3 C, is based on the location of amino-terminal cysteine residue(s) (Murphy et al., 2000) .
CXCR4 has been under intense study as a participant in a number of disease-related processes angiogenesis and human immunodeficiency virus (HIV) infection by virtue of its role as a major HIV-1 co-receptor (Gerard and Rollins, 2001; Hesselgesser et al., 1997; Moore et al., 1997; Proudfoot et al., 1999) . CXCR4 is widely expressed in many tissues and cells, including the brain (Baggiolini et al., 1997; Feil and Augustin, 1998; Hesselgesser et al., 1997; Ohtani et al., 1998; Tanabe et al., 1997; Volin et al., 1998) . At the same time, the opioid receptors have been found on neuronal cells of the brain, as well
